Takeda Again Sues Par Over Generic Gout Drug
Takeda Pharmaceuticals USA Inc. hit Par Pharmaceutical Cos. Inc. with a second patent suit Tuesday in Delaware federal court, claiming Par's revived effort to produce a generic gout medication infringes five...To view the full article, register now.
Already a subscriber? Click here to view full article